Tianjin Ringpu Bio-Technology Co.,Ltd. engages in the research and development, production, and sales of veterinary biological products, veterinary drug preparations, functional additives, and veterinary raw materials in China. The company provides vaccines and drugs for poultry, swine, and other animals; pet products comprising pet rabies inactivated vaccine, recombinant canine-a interferon, inhalation anesthetics isoflurane and sevoflurane for dogs and cats, cefquinoxime sulfate for injection for prevention and treatment of pet bacterial diseases, heart disease drugs for dogs and cats, napril chewable tablets and other products; and waterfowl products, including duck tempusu live/inactivated vaccine, gosling plague refined egg yolk antibody, duck infectious serositis inactivated vaccine, duck viral hepatitis refined egg yolk antibody, duck plague live vaccine, florfenicol soluble powder, kanamycin injection, etc. It also offers antifungal products, such as natural plant extracts, immune polysaccharides, clostridium butyricum, lactobacillus plantarum, antibacterial peptides, enzyme preparations, acidulants, etc; disinfection and cleaning products, consisting of potassium hydrogen persulfate composite powder, benzyl trimethyl ammonium chloride solution, deca methyl ammonium bromide solution, sodium dichloroisocyanurate, iodine glycerin solution, etc.; and APIs comprising tilmicosin, tilmicosin phosphate, monbutone, tidiroxine, florfenicol, vonimulin hydrochloride, gamimycin, etc. The company was founded in 1998 and is based in Tianjin, China.
Tianjin Ringpu Bio-Technology Dividend Announcement
• Tianjin Ringpu Bio-Technology announced a annually dividend of ¥0.40 per ordinary share which will be made payable on 2024-05-15. Ex dividend date: 2024-05-15
• Tianjin Ringpu Bio-Technology annual dividend for 2024 was ¥0.40
• Tianjin Ringpu Bio-Technology annual dividend for 2023 was ¥0.30
• Tianjin Ringpu Bio-Technology's trailing twelve-month (TTM) dividend yield is 2.08%
• Tianjin Ringpu Bio-Technology's payout ratio for the trailing twelve months (TTM) is 81.56%
• Tianjin Ringpu Bio-Technology's dividend growth over the last five years (2018-2023) was 14.87% year
• Tianjin Ringpu Bio-Technology's dividend growth over the last ten years (2013-2023) was 1.84% year
Tianjin Ringpu Bio-Technology Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-05-15 | ¥0.40 | annually | 2024-05-15 |
2023-06-08 | ¥0.30 | annually | 2023-06-08 |
2022-06-13 | ¥0.35 | annually | 2022-06-13 |
2021-04-22 | ¥0.40 | annually | 2021-04-22 |
2020-05-07 | ¥0.25 | annually | 2020-05-07 |
2019-05-24 | ¥0.15 | annually | 2019-05-24 |
2018-05-23 | ¥0.15 | annually | 2018-05-23 |
2017-05-25 | ¥0.15 | annually | 2017-05-25 |
2016-05-24 | ¥0.15 | annually | |
2015-05-22 | ¥0.10 | annually | |
2014-04-22 | ¥0.20 | annually | |
2013-05-09 | ¥0.25 | annually |
Tianjin Ringpu Bio-Technology Dividend per year
Tianjin Ringpu Bio-Technology Dividend growth
Tianjin Ringpu Bio-Technology Dividend Yield
Tianjin Ringpu Bio-Technology current trailing twelve-month (TTM) dividend yield is 2.08%. Interested in purchasing Tianjin Ringpu Bio-Technology stock? Use our calculator to estimate your expected dividend yield:
Tianjin Ringpu Bio-Technology Financial Ratios
Tianjin Ringpu Bio-Technology Dividend FAQ
Other factors to consider when evaluating Tianjin Ringpu Bio-Technology as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Tianjin Ringpu Bio-Technology stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Tianjin Ringpu Bio-Technology's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Tianjin Ringpu Bio-Technology publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Tianjin Ringpu Bio-Technology distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Tianjin Ringpu Bio-Technology are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Tianjin Ringpu Bio-Technology sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Tianjin Ringpu Bio-Technology distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Tianjin Ringpu Bio-Technology declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Tianjin Ringpu Bio-Technology's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Tianjin Ringpu Bio-Technology's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.